Detalhe da pesquisa
1.
Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer.
J Urol
; 206(5): 1166-1176, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34184929
3.
Intermittent androgen suppression for rising PSA level after radiotherapy.
N Engl J Med
; 367(10): 895-903, 2012 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22931259
4.
Mortality reduction and cumulative excess incidence (CEI) in the prostate-specific antigen (PSA) screening era.
Sci Rep
; 14(1): 5810, 2024 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461151
5.
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study.
Radiother Oncol
; 183: 109599, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889593
6.
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
J Clin Oncol
; 41(24): 4035-4044, 2023 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315297
7.
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
Radiother Oncol
; 184: 109672, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059334
8.
MRI-defined treatment margins, urinary toxicity, and PSA response in LDR prostate brachytherapy.
Brachytherapy
; 21(2): 216-223, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210018
9.
Raman spectroscopy and supervised learning as a potential tool to identify high-dose-rate-brachytherapy induced biochemical profiles of prostate cancer.
J Biophotonics
; 15(11): e202200121, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908273
10.
Prediction of disease progression indicators in prostate cancer patients receiving HDR-brachytherapy using Raman spectroscopy and semi-supervised learning: a pilot study.
Sci Rep
; 12(1): 15104, 2022 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068275
11.
Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature.
Oncol Ther
; 9(1): 21-39, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33454930
12.
The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy.
Eur Urol
; 79(4): 446-452, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33390282
13.
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement.
Brachytherapy
; 20(6): 1114-1129, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34509378
14.
A biochemical definition of cure after brachytherapy for prostate cancer.
Radiother Oncol
; 149: 64-69, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32442822
15.
Salvage Local Treatments After Focal Therapy for Prostate Cancer.
Eur Urol Oncol
; 2(5): 526-538, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31412013
16.
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526).
Int J Radiat Oncol Biol Phys
; 103(2): 335-343, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30312717
17.
Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.
Brachytherapy
; 7(2): 200-5, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18362087
18.
Inter-institutional variation of implant activity for permanent prostate brachytherapy.
Brachytherapy
; 7(4): 297-300, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18786866
19.
The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer.
Transl Androl Urol
; 7(3): 414-435, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30050801
20.
The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
Brachytherapy
; 6(3): 173-9, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17681239